AC

ACRO Biomedical Co LtdOOTC ACBM Stock Report

Last reporting period 30 Jun, 2023

Updated —

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

ACBM Stock Analysis

AC

Uncovered

ACRO Biomedical Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-39/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

60.042 B

Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. The company is headquartered in Fishers, Indiana. The company went IPO on 2016-06-23. The Company’s business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus, which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The company purchases products from suppliers in the Republic of China (Taiwan). The firm sells its product in bulk to companies who uses its products as ingredients in their products or sell the products they purchase from Company to their own customers.

View Section: Eyestock Rating